ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Rejecting Data, Believers In PSA Screening Strengthen Guidelines, Launch Outreach

September 11, 2009

Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored

December 10, 1982

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

June 1, 2001

Cancer Panel Urges Improved Funding For Basic Science

June 16, 1995

Breast Cancer Task Force to Issue New RFPs In July, September

July 9, 1976